RxDoctor Payments Data

Lauren Andrews, APRN

Psychiatric/Mental Health · Fort Smith, ARNPI 1821752825

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $3,750 of the $6,067 with a category attached, or 61.8%. AbbVie accounts for 69.7% of it on its own, with 28 other manufacturers making up the rest. 2025 is the largest year on record at $4,330, 3.0 times the $1,459 reported in 2022. Among psychiatric/mental health clinicians in AR with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,067in general payments, 2019–2025

Across 110 payments — averaging $55.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$4K
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$233
  • AstraZeneca$221
  • Novo Nordisk$179
  • Sanofi-aventis U.S. LLC$146
  • Vanda Pharmaceuticals Inc.$139
  • plus $918 from 23 others

What the payments were for

  • Speaking & faculty fees$3,75062%
  • Food & beverage$2,31738%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,067 in reported general payments places this provider in the 90th percentile of 359 psychiatric/mental health providers in Arkansas.

See all psychiatric/mental health providers in Arkansas

Medicare billing

Part B allowed, 2024
$8,563
Medicare patients
28
Services billed
184

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Duloxetine Hcl46$1,012
Oxcarbazepine12$910
Quetiapine Fumarate43$753
Aripiprazole66$732
Hydroxyzine Hcl23$662
Buspirone Hcl39$418
Bupropion XlBupropion Hcl23$345
Lamotrigine32$344
Divalproex Sodium ErDivalproex Sodium18$343
Risperidone14$248
Benztropine Mesylate11$193
Prazosin Hcl21$170
Trazodone Hcl34$143
Venlafaxine Hcl ErVenlafaxine Hcl12$126
Sertraline Hcl41$123

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Fort Smith

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →